Source Post
Novo Nordisk Down 60% - Why I’m SLASHING My Price Target (Full Analysis)
May 10, 2025
The creator analyzes Novo Nordisk (NVO), noting its significant stock price decline over the past year and year-to-date. Despite the drop, the creator highlights a severely undervalued valuation based on forward P/E and a historical comparison, along with an attractive dividend yield. While acknowledging some concerning aspects from recent earnings, the overall valuation signals suggest a potential buying opportunity.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.